UPLOAD Filing
Aptose Biosciences Inc.
Date: April 28, 2025 · CIK: 0000882361 · Accession: 0000000000-25-004492
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-32001
Letter
Re: Aptose Biosciences Inc. Preliminary Proxy Statement on Schedule 14A Filed April 23, 2025 File No. 001-32001 Dear William Rice:
April 28, 2025
William Rice Chief Executive Officer Aptose Biosciences Inc. 12770 High Bluff Drive, Unit 120 San Diego, CA 92130
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
cc: Daniel M. Miller, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 28, 2025 William Rice Chief Executive Officer Aptose Biosciences Inc. 12770 High Bluff Drive, Unit 120 San Diego, CA 92130 Re: Aptose Biosciences Inc. Preliminary Proxy Statement on Schedule 14A Filed April 23, 2025 File No. 001-32001 Dear William Rice: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Daniel M. Miller, Esq. </TEXT> </DOCUMENT>